ResearcherSociedad Española de Oncología MédicaActive in the last 2 years
Jorge Aparicio
Matched on ORCID iD 0000-0001-5527-0786; OpenAlex author ID A5060170484. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2014: 2 papers · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Real-world outcomes of FOLFIRINOX versus gemcitabine plus nab-paclitaxel and prognostic factors in advanced pancreatic cancer: a retrospective cohort study. Co-author DOI 10.1177/17588359261456797↗
- Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies. Last author DOI 10.1007/s12094-016-1609-7↗
- Erratum to: Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies. Last author DOI 10.1007/s12094-017-1636-z↗
- A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Gru… Co-author DOI 10.1371/journal.pone.0082209↗
- Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical practice. Co-author DOI 10.6092/1590-8577/1570↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Robert Díaz Beveridge · 2 shared papers, 2014–2026 · strength 0.32
- Paper Real-world outcomes of FOLFIRINOX versus gemcitabine plus nab-paclitaxel and prognostic factors in advanced pancreatic … DOI 10.1177/17588359261456797↗
- Paper Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical pract… DOI 10.6092/1590-8577/1570↗
- Carlos Escriva-Aranda · 1 shared paper, 2026 · strength 0.28
- Ruth Vera · 2 shared papers, 2017 · strength 0.12
- Paper Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between … DOI 10.1007/s12094-016-1609-7↗
- Paper Erratum to: Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consen… DOI 10.1007/s12094-017-1636-z↗
- Eva Cristina Vaquero · 2 shared papers, 2017 · strength 0.12
- Paper Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between … DOI 10.1007/s12094-016-1609-7↗
- Paper Erratum to: Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consen… DOI 10.1007/s12094-017-1636-z↗
- Joaquín Montalar · 1 shared paper, 2014 · strength 0.04
- Carlos Conill · 1 shared paper, 2014 · strength 0.04
- Joan Maurel · 1 shared paper, 2014 · strength 0.04
- Marta Martín-Richard · 1 shared paper, 2014 · strength 0.04
- Jaime Feliú · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.